Radiation therapy agent
Provided is a radiotherapeutic agent, including a composite particle, which is obtained by binding a molecule that specifically recognizes a target to a substrate particle including titanium peroxide, and which generates reactive oxygen through irradiation with a radiation. Further, because the radiotherapeutic agent contains the molecule that specifically recognizes a target, the radiotherapeutic agent has a function of accumulating in the target. The radiotherapeutic agent is capable of enhancing effects of radiotherapy, and is capable of reducing side effects on a living body to efficiently attack the target.
1. A radiotherapeutic agent, comprising a composite particle, which is obtained by binding a molecule that specifically recognizes a target to a substrate particle comprising titanium peroxide, and which generates reactive oxygen that damages the target through X-ray irradiation.
2. A radiotherapeutic agent according to claim 1 , wherein the reactive oxygen comprises a hydroxyl radical.
3. A radiotherapeutic agent according to claim 1 , wherein the titanium peroxide in the substrate particle is mainly distributed on a surface of the substrate particle.
4. A radiotherapeutic agent according to claim 1 , wherein the substrate particle further comprises titanium dioxide.
5. A radiotherapeutic agent according to claim 1 , wherein the substrate particle has an average dispersed particle diameter of 1 nm or more to 200 nm or less.
6. A radiotherapeutic agent according to claim 1 , wherein the molecule that specifically recognizes a target comprises an antibody.
7. A radiotherapeutic agent according to claim 1 , wherein the composite particle comprises the substrate particle whose surface is at least partially coated with a polymer coating film, and is obtained by binding the molecule that specifically recognizes a target to the substrate particle via the polymer coating film.
8. A dispersion liquid, comprising a composite particle self-dispersed in water, a pH buffer, an infusion liquid, or physiological saline, wherein the composite particle comprises a composite particle, which is obtained by binding a molecule that specifically recognizes a target to a substrate particle comprising titanium peroxide, and which generates reactive oxygen that damages the target through X-ray irradiation.
9. A dispersion liquid according to claim 8 , wherein the composite particle has a surface potential of +20 mV or more.
10. A radiotherapeutic agent, comprising the dispersion liquid according to claim 8 .
11. An antitumor agent, comprising the radiotherapeutic agent according to claim 1 , wherein the molecule that specifically recognizes a target comprises an antibody capable of specifically recognizing a tumor cell.